(Reuters) -Heartflow, an artificial intelligence-based medical device software developer, filed for an initial public offering in the United States on Thursday.

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by trade policy uncertainty under President Donald Trump, earlier this year.

Heartflow will list on the Nasdaq under the symbol "HTFL".

J.P. Morgan, Morgan Stanley and Piper Sandler are among the underwriters for the offering.